Seòmar agus comataidhean

I refer the member to the answer to question S6W-05156 on 10 January 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

I refer the member to the answer to question S6W-05156 on 10 January 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The Scottish Government does not hold information on temporary closures of community pharmacies or the possible cost incurred by the NHS.

The provision of community pharmacy pharmaceutical care services are the responsibility of territorial Health Boards as set out in the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009. Any challenges faced by community pharmacies in ensuring the safe and effective dispensing of treatments should be discussed with the local Health Board.

A variety of risk assessments are undertaken across all wards in the Hospital, including 4a and 4b, covering social distancing, hand hygiene, infection control precautions (SICPs) audits every 6 months, patient placement, and the verification of the specialist ventilation systems in ward 4b. The new and innovative Infection Prevention and Control (IPC) dashboard available to all staff enables real time review of IPC data, and allows for a quick and effective response to any risks reported.

Because of the unpredictable lifecycle of this particular organism, it is not possible to routinely test buildings for an Aspergillus infection. Where water ingress creates the conditions for mould, NHS Greater Glasgow and Clyde’s staff work to remedy faults as soon as they are found and remove any mould with oversight from Infection Prevention and Control (IPC). Patients with Aspergillus are visited by an infection prevention and control nurse. Advice on the correct antibiotics to administer to patients is given by a Microbiology/ICD/antimicrobial pharmacist on request of the clinical teams.

There are no plans to introduce protected learning time at present. It is a decision for employers to allow staff time to study for additional qualifications.

To support delivery of the Community Pharmacy First Plus service, Community Pharmacist contractors receive backfill (up to £5750) to release community pharmacists to undertake their IP qualification (5 days face to face teaching + 12 days Period of Learning in Practice), clinical skills training (4 days) and also access to a maximum of 3 sessions at a CCC Teach and Treat Training Hub (backfill up to £750).

The pharmacy profession and provision of pharmaceutical care is regulated by the General Pharmaceutical Council, who assure and improve standards of care for people using pharmacy services. The Achieving Excellence in Pharmaceutical Care strategy, published in 2017, setting out the priorities, commitments, and actions for improving and integrating NHS pharmaceutical care in Scotland up to 2022. The strategy sets the direction for how pharmaceutical care would be delivered in Scotland and the crucial contribution of pharmacists and pharmacy technicians, working together with other health and social care practitioners, to improve the health of the population and impact on health outcomes.

The information requested regarding whether the Health and Safety Executive (HSE) has carried out any investigation into deaths due to hospital-acquired infection at the Queen Elizabeth University Hospital is not centrally held by the Scottish Government.

Health and safety at work is a reserved matter. HSE has confirmed that their published policy is generally not to investigate hospital acquired infections Who regulates health care (hse.gov.uk) . They have not investigated deaths at the Queen Elizabeth University Hospital that may have been caused by a hospital associated infection.

HSE did however carry out an investigation into concerns raised with them in December 2019 about the ventilation within two wards at the Queen Elizabeth University Hospital and the control of legionella in water systems across the hospital.

HSE was satisfied with the control of legionella but wrote to the Chief Executive of Greater Glasgow Health Board/NHS Greater Glasgow and Clyde requesting improvements to the ventilation systems. An Improvement Notice was served in relation to the ventilation system within Ward 4C.

Further information is available on the NHS GGC webpage: https://www.nhsggc.org.uk/about-us/media-centre/news/2019/12/hse-improvement-notice/ . The Improvement Notice is being appealed by the Health Board. However, HSE is satisfied that appropriate remedial action has been taken.

The information requested regarding whether the Health and Safety Executive (HSE) has invoked a Divisional Major Incident Response Plan, in relation to deaths due to hospital associated infection at the Queen Elizabeth University Hospital, is not centrally held by the Scottish Government.

Health and safety at work is a reserved matter. HSE has confirmed that the issues raised with them did not meet the criteria for a ‘Divisional Major Incident’ as outlined in their published response plans og-00076-appendix-4.pdf (hse.gov.uk) .

The pharmacy profession and the provision of pharmaceutical services are highly regulated, overseen by the General Pharmaceutical Council (GPhC). The GPhC's role includes upholding health and safety standards for the pharmacy workforce, as well as for patients.

The Scottish Government regularly meets with Community Pharmacy Scotland, the representative body for pharmacy owners, to discuss a range of topics including workforce issues, including health and wellbeing. This year the Scottish Government has made £12m available to support the wellbeing of the pharmacist workforce. This includes £8m from the NHS Recovery Plan to provide ongoing wellbeing support for the workforce – alongside an extra £4m to provide further support to address winter pressures.

The funding supports the 24/7 National Wellbeing Helpline, our National Wellbeing Hub, Coaching for Wellbeing and the Workforce Specialist Service, alongside tailored psychological interventions for staff, providing individualised wellbeing support focusing on people’s physical and emotional needs.

The Chief Pharmaceutical Officer for Scotland in a joint letter (8 December 2021) with the leaders from the pharmacy sector, including the Royal Pharmaceutical Society (Scotland), has written to all pharmacy teams outlining the range of wellbeing support available to pharmacy teams and encouraging them to access these resources for support when needed.